Health Care

Shanghai stocks lost ground on Wednesday despite China's better-than-expected economic growth in the second quarter, with investors still wary after a big slide in Chinese markets.

U.S. stocks mostly rose as trading opened Monday with investors looking ahead to a busy week for earnings news and a meeting by the Federal Reserve on interest rates.

U.S. stock indexes are moving higher as the market rebounds from a loss the day before.

U.S. stock indexes are opening slightly higher as the market rebounds from a loss the day before.

India's top court rejected the Swiss drugmaker's plea for patent protection of its cancer drug Glivec, a move likely to boost the prospects of Indian pharmaceutical firms over their foreign rivals.

The latest developments in the sentencing of a former peanut company executive convicted in a deadly salmonella outbreak from 2008 and 2009.

Federal prosecutors are set to announce a settlement with General Motors that resolves a criminal investigation into how the Detroit automaker concealed a deadly problem with small-car ignition switches, according to three people briefed on the case.

ConAgra Foods is likely to face a criminal charge now that the U.S. government has completed its investigation of the company's 2007 peanut butter recall.

Federal prosecutors are asking a judge to consider the "widespread harm" done by a nationwide salmonella outbreak in sentencing two egg industry executives whose company was responsible.

A federal grand jury in Texas has indicted the CEO of Minnesota-based medical device maker Vascular Solutions Inc. on charges he conspired to sell a varicose-vein treatment device for unapproved uses.

Chinese authorities have formally indicted two corporate investigators, an American and Briton, for allegedly illegally obtaining and selling private information.

GlaxoSmithKline posted an improvement in third-quarter core earnings; however, sales in China toppled 61%.

GlaxoSmithKline said some of its executives in China appeared to have breached Chinese law related to an ongoing bribery scandal. 

Chinese police accused GlaxoSmithKline of reportedly bribing officials and doctors by channeling money through travel agencies. 

GlaxoSmithKline has so far found no evidence of bribery in China related to past sales of Botox despite fresh allegations that it paid doctors cash and other benefits to prescribe the treatment.

The prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection and says it has reached a financial restructuring agreement with investors holding more than $520 million in debt.

Prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection with a plan that leads to either a sale of the company or a takeover by its lenders.

Spiders have forced Suzuki to recall more than 19,000 midsize cars.

Eli Lilly reaffirmed its financial goals, though it said getting there may require cost cutting due to patent expirations and other issues.

Novo Nordisk was handed an upgrade to 'buy' from 'hold' on Tuesday from Austria's Erste Group.